Skip to main content

Table 1 Population

From: Feasibility and safety of deep sedation with propofol and remifentanil in spontaneous breathing during endoscopic retrograde cholangiopancreatography: an observational prospective study

PARAMETERS

VALUE

PATIENTS

106

GENDER (male/female)

54/52

AGE, mean (SD)

71 (12,37)

BMI, mean (SD)

25,81 (20,14)

Underweight, < 18,5 (%)

2,91

Normal, 18,5–24,9 (%)

35,89

Overweight, 25–29,9 (%)

38,8

Obesity I, 30–34,9 (%)

12, 61

Obesity II, 35–39,9 (%)

0

Obesity III, > 40 (%)

2,91

SMOKE (%)

 

Yes

11,9

No

43,35

Ex

17

ALCOHOL (%)

0,92

COMORBIDITIES

 

Ictus Cerebri (%)

6,84

High Blood Pressure (%)

63,19

Metabolic Disorders (%)

25,11

Chronic Kidney Disease (%)

12,18

Chronic Liver Disease (%)

12,04

Chronic Cardiac Disease (%)

42,75

Anticoagulant Therapy (%)

13,6

Antiplatelet Therapy (%)

33,12

Benzodiazepines (%)

2,58